Stemcell Institute operates Japan's largest private cord blood banking service, collecting, processing, and cryogenically storing cord blood and umbilical cord tissue from newborns for potential future autologous regenerative medicine and cell therapy use. The company processes samples at its cell processing centers in Tokyo and Yokohama, holding approximately 94,683 cumulative cord blood units and 13,210 cord tissue units as of March 2025, representing the dominant market share among Japan's two registered private cord blood banks. Beyond banking, the company is developing new therapeutic applications of stored cells targeting conditions such as cerebral palsy, hypoxic-ischemic encephalopathy, and autism spectrum disorder, with additional investment activity in regenerative medicine, fertility treatment, and childcare-related businesses.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Stemcell Institute operates Japan's largest private cord blood banking service, collecting, processing, and cryogenically storing cord blood and umbilical cord tissue from newborns for potential future autologous regenerative medicine and cell therapy use. The company processes samples at its cell processing centers in Tokyo and Yokohama, holding approximately 94,683 cumulative cord blood units and 13,210 cord tissue units as of March 2025, representing the dominant market share among Japan's two registered private cord blood banks. Beyond banking, the company is developing new therapeutic applications of stored cells targeting conditions such as cerebral palsy, hypoxic-ischemic encephalopathy, and autism spectrum disorder, with additional investment activity in regenerative medicine, fertility treatment, and childcare-related businesses.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →